Characterization of lymphopenia in patients with MS treated with dimethyl fumarate and fingolimod
Citation Manager Formats
Make Comment
See Comments
See original article:

In the Article "Characterization of lymphopenia in patients with MS treated with dimethyl fumarate and fingolimod" by M. Nakhaei-Nejad et al.1, there are typographical errors in the Abstract, which should use “CD4+”, “CD8+”, “CD27+IgD-“, and “CD27+” rather than “CD41,” “CD81,” CD271IgD2,” and “CD271” as originally published. The publisher regrets the errors.
- © 2018 American Academy of Neurology
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. Sevil Yaşar and Dr. Behnam Sabayan
► Watch
Related Articles
Alert Me
Recommended articles
-
Article
Different Fumaric Acid Esters Elicit Distinct Pharmacologic ResponsesBrian T. Wipke, Robert Hoepner, Katrin Strassburger-Krogias et al.Neurology: Neuroimmunology & Neuroinflammation, January 19, 2021 -
Research
Lymphocyte reconstitution after DMF discontinuation in clinical trial and real-world patients with MSAndrew Chan, John Rose, Enrique Alvarez et al.Neurology: Clinical Practice, January 02, 2020 -
Article
Characterization of lymphopenia in patients with MS treated with dimethyl fumarate and fingolimodMaryam Nakhaei-Nejad, David Barilla, Chieh-Hsin Lee et al.Neurology: Neuroimmunology & Neuroinflammation, December 28, 2017 -
Research
Characterizing absolute lymphocyte count profiles in dimethyl fumarate–treated patients with MSPatient management considerationsRobert J. Fox, Andrew Chan, Ralf Gold et al.Neurology: Clinical Practice, April 01, 2016